FdaApplication
NDA 205831
Identifiers
- fda_app_no: NDA205831
Properties
| Property | Value |
|---|---|
| applicant_name | RHODES PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2015-04-17 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE | 10MG | CAPSULE, EXTENDED RELEASE;ORAL |
| APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE | 40MG | CAPSULE, EXTENDED RELEASE;ORAL |
| APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
| APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE | 20MG | CAPSULE, EXTENDED RELEASE;ORAL |
| APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
| APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE | 15MG | CAPSULE, EXTENDED RELEASE;ORAL |
| APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
7 products